Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic

Journal of Urban Health

Volumn 82, Issue 2, 2005, Pages 216-224

  Jandorf, Lina ^a   Gutierrez, Yahaira ^a   Lopez, Jaime ^b   Christie, Jennifer ^a   Itzkowitz, Steven H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Settlement Health Center   (United States)

Author keywords

Colorectal cancer screening; Fecal occult blood test; Flexible sigmoidoscopy; Urban health

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SIGMOIDOSCOPY; SOCIAL STATUS; URBAN AREA;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; COMMUNITY HEALTH CENTERS; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HEALTH SERVICES ACCESSIBILITY; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; PHYSICIAN-PATIENT RELATIONS; SIGMOIDOSCOPY; SOCIOECONOMIC FACTORS; URBAN HEALTH SERVICES;

EID: 24044550955     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: 10.1093/jurban/jti046     Document Type: Article

References (16)

1. Greenlee RT, Hill-Harmonn MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001;51:15-36.
2. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5-26.
3. Cancer Prevention and Control. Comparison of use of colorectal cancer tests with other cancer screening tests, NHIS 2000. Available at: http://www.cdc.gov/cancer/colorctl/calltoaction/slides_index.htm (slide35). Accessed April 11, 2005.
4. National Cancer Institute. SEER cancer statistics review 1973-1997. Available at: http://seer.cancer.gov/csr/1973_1997/colorect.pdf. Accessed April 5, 2005.
5. Behavioral Risk Factor Surveillance System. Technical information and data. Available at: http://www.cdc.gov/brfss/technical_infodata/surveydata/1997. htm. Accessed April 5, 2005.
6. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365-1371.
7. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603-1607.
8. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-1477.
9. Burt RW. Colon cancer screening. Gastroenterology. 2000;119:837-853.
10. Newcomb PA, Norfleet RG, Storer E, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572-1575.
11. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-702.
12. Tingen MS, Weinrich SP, Heydt DD, Boyd MD, Weinrich MC. Perceived benefits: a predictor of participation in prostate cancer screening. Cancer Nurs. 1998;21:349-357.
13. Frelix GD, Rosenblatt R, Solomon M, Vikram B. Breast cancer screening in underserved women in the Bronx. J Natl Med Assoc. 1999;91:195-200.
14. Freeman HP, Muth BJ, Kerner JF. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract. 1995;3:19-30.
15. Gauthier MA, Clarke WP. Gaining and sustaining minority participation in longitudinal research projects. Alzheimer Dis Assoc Disord. 1999;13:S29-S33.
16. Stoy DB, Curtis RC, Dameworth KS, et al. The successful recruitment of elderly black subjects in a clinical trial: the CRISP experience. Cholesterol Reduction in Seniors Program. J Natl Med Assoc. 1995;87:280-287.